KRT7-AS: A Non-Coding RNA Molecule with Potential as A Drug Target Or Biomarker

Target Name: KRT7-AS

NCBI ID: G109729127

Other Name(s): KRT7 antisense RNA 1

KRT7-AS: A Non-Coding RNA Molecule with Potential as A Drug Target Or Biomarker

KRT7-AS (KRT7 antisense RNA 1) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. Its unique structure and function have made it an attractive target for researchers to investigate.

KRT7 is a gene that encodes a protein known as KRT7, which is a key regulator of the microRNA (miRNA) pathway. This pathway is responsible for regulating gene expression by cutting down the number of copies of certain genes. KRT7 plays a crucial role in regulating the expression of genes involved in cell growth, differentiation, and survival.

As a result of its role in regulating gene expression, KRT7 has been linked to a number of diseases, including cancer, neurodegenerative diseases, and developmental disorders. Researchers have also found that KRT7 is often expressed at high levels in cancer cells, which suggests that it may be a promising target for cancer treatments.

In addition to its potential as a drug target, KRT7 has also been identified as a potential biomarker. Its expression has been found to be altered in a number of diseases, including cancer, neurodegenerative diseases, and cardiovascular disease. This makes it a promising candidate for use as a diagnostic or predictive marker in these diseases.

One of the challenges in studying KRT7 is its complex structure. Unlike most proteins, KRT7 is not a single chain, but rather a double-stranded RNA molecule that has a partially open circlet structure. This structure makes it difficult to study the protein's function, as researchers have difficulty predicting how the protein will behave in different conditions.

Despite these challenges, researchers have made significant progress in understanding the function of KRT7. Studies have shown that KRT7 plays a role in regulating the expression of genes involved in cell growth, differentiation, and survival. They have also found that KRT7 is expressed at high levels in cancer cells, which suggests that it may be a promising target for cancer treatments.

In addition to its potential as a drug target, KRT7 has also been identified as a potential biomarker. Its expression has been found to be altered in a number of diseases, including cancer, neurodegenerative diseases, and cardiovascular disease. This makes it a promising candidate for use as a diagnostic or predictive marker in these diseases.

Overall, KRT7-AS is a promising molecule for drug targeting and biomarker research. Its unique structure and function make it an attractive target for researchers to investigate, and its potential as a drug and biomarker has significant implications for the development of new therapies.

Protein Name: KRT7 Antisense RNA 1

More Common Targets